ChemicalBook Chinese Germany Japanese Korean

TargetMol中国（陶术生物） Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -
Email:    marketing@targetmol.cn
Nationality:    China
WebSite:    https://www.targetmol.cn/
Product List:    29243
92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196
Product List
Rucaparib acetate 773059-23-7
PI3Kα-IN-9 2715287-67-3
Vonoprazan hydrochloride 1957202-44-6
α-Synuclein inhibitor 6 2489813-02-5
Quinoprazine 115618-99-0
PREP inhibitor-1 2760543-16-4
α-Synuclein inhibitor 4 2489813-08-1
ATX inhibitor 15 2484811-52-9
NPEC-caged-LY379268 1315379-62-4
Sulindac sodium 63804-15-9
Antitubercular agent-12 905677-04-5
Anticancer agent 83 904815-29-8
BuChE-IN-5 2402753-39-1
BF844 1404506-35-9
sEH inhibitor-6 1205963-04-7
USP15-IN-1 2260826-16-0
FNDR-20123 free base 1267502-34-0
KDM2B-IN-4 1966933-85-6
F15845 470454-73-0
P2X7 receptor antagonist-2 851269-75-5
Antiparasitic agent-10 2138480-87-0
NJH-2-030 2709040-02-6
CB1R Allosteric modulator 3 2633686-36-7
Glyoxalase I inhibitor 3 1415388-25-8
DMA-135 hydrochloride 2237925-62-9
BRD4 Inhibitor-15 2761366-60-1
Immunoproteasome inhibitor 1 2755772-63-3
AIMP2-DX2-IN-1 848256-17-7
Onfasprodil 1892581-29-1
Antitumor agent-70 2454133-88-9
Chromenone 1 1639929-29-5
RBP4 inhibitor 1 1198180-03-8
HIF-PHD-IN-2 2711720-45-3
TRβ agonist 2 2411099-30-2
SIRT5 inhibitor 4 708992-34-1
BSP16 2727249-47-8
HPK1-IN-26 2229042-24-2
4-PQBH 2243355-51-1
OD36 hydrochloride 2387510-88-3
LUF7244 1821638-43-0
TRPC3/6-IN-1 736945-96-3
InhA-IN-4 894309-72-9
α-Synuclein inhibitor 3 2687831-18-9
CB1R Allosteric modulator 4 2633686-53-8
CXCR2 antagonist 2 2647464-91-1
Diaziquone 57998-68-2
TGFβ1-IN-1 2348795-14-0
Chitin synthase inhibitor 3 2416338-26-4
PGN36 1564253-75-3
FPI-1602 1452460-31-9
Peficitinib hydrochloride 1353219-06-3
Fosphenytoin 93390-81-9
A-908292 903886-95-3
VO-OHPic 675848-25-6
RSV/IAV-IN-1 2395007-77-7
Monoacylglycerol lipase inhibitor 1 2714570-98-4
HIV-1 inhibitor-37 2416971-40-7
HIV-1 inhibitor-30 2132412-77-0
ML233 2080311-92-6
FGFR2-IN-2 2677709-81-6
(R)-ND-336 2252493-33-5
Idoxuridine hydrate 17140-71-5
Sulfisoxazole diethanolamine 4299-60-9
PI3K/mTOR Inhibitor-3 1363338-53-7
Topoisomerase I inhibitor 5 2513461-95-3
PBENZ-DBRMD 1454662-41-9
Ruzotolimod 1948241-60-8
GAL-021 sulfate 1380342-00-6
Dichlorphenamide disodium 76382-13-3
DDO-02005 free base 1186134-30-4
Alinidine hydrobromide 71306-36-0
RSV-IN-3 862825-90-9
(Rac)-Upacicalcet 2649575-19-7
Steroid sulfatase-IN-2 2413880-39-2
FPI-1465 1452458-70-6
HIV-1 inhibitor-36 2170506-18-8
Topiramate lithium 488127-53-3
ALK5-IN-8 2705900-81-6
Metallo-β-lactamase-IN-5 1417737-65-5
VEGFR-2-IN-19 2456315-41-4
HIF-1α-IN-3 2170715-64-5
TDO-IN-1 2490672-92-7
SSAO/VAP-1 inhibitor 1 2647975-06-0
Carbonic anhydrase inhibitor 2 2758231-43-3
Febuxostat sodium 1140907-13-6
Pirifibrate 55285-45-5
Piperilate 4546-39-8
Glyoxalase I inhibitor 5 2455508-17-3
Exo2 304684-77-3
GPR40 agonist 6 1798751-25-3
HPGDS inhibitor 3 2255311-93-2
Glyoxalase I inhibitor 7 2455508-31-1
CB1R Allosteric modulator 2 2513102-64-0
RSV/IAV-IN-2 2395007-75-5
STAT3-IN-11 2503096-50-0
Tilomisole 58433-11-7
Type II topoisomerase inhibitor 1 2245691-60-3
HN37 1821222-10-9
RUNX1/ETO tetramerization-IN-1 88755-39-9
Tubulin polymerization-IN-15 2055517-66-1
92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196
Copyright 2007©  ChemicalBook. All rights reserved.